Long-term safety and efficacy of lanreotide treatment in Japanese patients with neuroendocrine tumors: Final analysis of a phase II open-label extension study

被引：0
|
作者：
Ito, Tetsuhide
Hisamatsu, Seiichi
Nakajima, Akihiro
Shimatsu, Akira
机构：
[1] Int Univ Hlth & Welf, Fukuoka Sanno Hosp, Neuroendocrine Tumor Ctr, Grad Sch Med,Dept Gastroenterol & Hepatol, Fukuoka, Japan
[2] Teijin Pharma Ltd, Tokyo, Japan
[3] Natl Hosp Org Kyoto Med Ctr, Clin Res Inst, Kyoto, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
621
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Long-term safety and efficacy of lanreotide autogel in Japanese patients with neuroendocrine tumors: Final results of a phase II open-label extension study
    Ito, Tetsuhide
    Fujimori, Nao
    Honma, Yoshitaka
    Kudo, Atsushi
    Hijioka, Susumu
    Katsushima, Shinji
    Kimura, Yasutoshi
    Fukutomi, Akira
    Hisamatsu, Seiichi
    Nakajima, Akihiro
    Shimatsu, Akira
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2021, 17 (05) : E153 - E161
  • [2] Long-Term Safety/Tolerability of Lanreotide Autogel/Depot (LAN) in Neuroendocrine Tumors (NETs) Patients With Carcinoid Syndrome (CS): The ELECT Long-Term Open-label Extension
    Vinik, Aaron
    Fisher, George, Jr.
    Kunz, Pamela
    Liyanage, Nilani
    Mirakhur, Beloo
    Lowenthal, Susan Pitman
    Pommier, Rodney
    Shaheen, Montaser
    Wolin, Edward
    [J]. PANCREAS, 2017, 46 (03) : 437 - 437
  • [3] LONG-TERM EFFICACY AND SAFETY OF LANADELUMAB: FINAL RESULTS FROM THE HELP OPEN-LABEL EXTENSION STUDY
    Banerji, A.
    Hao, J.
    Yu, M.
    Bernstein, J.
    Johnston, D.
    Riedl, M.
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2020, 125 (05) : S21 - S21
  • [4] LONG-TERM SAFETY AND EFFICACY OF RISANKIZUMAB TREATMENT IN PATIENTS WITH CROHN'S DISEASE: FINAL RESULTS FROM THE PHASE 2 OPEN-LABEL EXTENSION STUDY
    Ferrante, Marc
    Feagan, Brian G.
    Panes, Julian
    Baert, Filip J.
    Louis, Edouard
    Dewit, Olivier
    Kaser, Arthur
    Duan, Weijiang
    Gustafson, Dawn
    Liao, Xiaomei
    Wallace, Kori
    Kalabic, Jasmina
    D'Haens, Geert R.
    [J]. GASTROENTEROLOGY, 2020, 158 (06) : S1198 - S1198
  • [5] Long-term safety and efficacy of risankizumab treatment in patients with Crohn's disease: Final results from the Phase 2 open-label extension study
    Ferrante, M.
    Feagan, B. G.
    Panes, J.
    Baert, F.
    Louis, E.
    Dewit, O.
    Kaser, A.
    Duan, W. R.
    Gustafson, D.
    Liao, X.
    Wallace, K.
    Kalabic, J.
    D'Haens, G. R.
    [J]. JOURNAL OF CROHNS & COLITIS, 2020, 14 : S024 - S025
  • [6] An open-label long-term phase III extension trial to evaluate the safety and efficacy of pregabalin in Japanese patients with fibromyalgia
    Ohta, Hiroyoshi
    Oka, Hiroshi
    Usui, Chie
    Ohkura, Masayuki
    Suzuki, Makoto
    Nishioka, Kusuki
    [J]. MODERN RHEUMATOLOGY, 2013, 23 (06) : 1108 - 1115
  • [7] Long-term safety of brodalumab in Japanese patients with plaque psoriasis: An open-label extension study
    Yamaguchi, Yukie
    Takatsu, Nobumichi
    Ootaki, Kenji
    Nakagawa, Hidemi
    [J]. JOURNAL OF DERMATOLOGY, 2020, 47 (06): : 569 - 577
  • [8] Safety and efficacy of tofacitinib for treatment of ulcerative colitis: final analysis of OCTAVE Open, an open-label, long-term extension study with up to 7.0 years of treatment
    Sandborn, William J.
    Lawendy, Nervin
    Danese, Silvio
    Su, Chinyu
    Loftus, Edward V., Jr.
    Hart, Ailsa
    Dotan, Iris
    Damiao, Aderson O. M. C.
    Judd, Donna T.
    Guo, Xiang
    Modesto, Irene
    Wang, Wenjin
    Panes, Julian
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2022, 55 (04) : 464 - 478
  • [9] Long-term efficacy and safety of eculizumab in Japanese patients with generalized myasthenia gravis: A subgroup analysis of the REGAIN open-label extension study
    Murai, Hiroyuki
    Uzawa, Akiyuki
    Suzuki, Yasushi
    Imai, Tomihiro
    Shiraishi, Hirokazu
    Suzuki, Hidekazu
    Okumura, Meinoshin
    O'Brien, Fanny
    Wang, Jing-Jing
    Fujita, Kenji P.
    Utsugisawa, Kimiaki
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2019, 407
  • [10] Long-Term Treatment With Evolocumab Among Japanese Patients - Final Report of the OSLER Open-Label Extension Studies
    Hirayama, Atsushi
    Yamashita, Shizuya
    Ruzza, Andrea
    Inomata, Hyoe
    Cyrille, Marcoli
    Lu, Chen
    Hamer, Andrew W.
    Yoshida, Masayuki
    Kiyosue, Arihiro
    Teramoto, Tamio
    [J]. CIRCULATION JOURNAL, 2019, 83 (05) : 971 - 977
12345